This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Binns, H. J.
Right arrow Articles by Saunders, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Binns, H. J.
Right arrow Articles by Saunders, S.
Related Collections
Right arrow Therapeutics & Toxicology

PEDIATRICS Vol. 103 No. 1 January 1999, pp. 100-106

Evaluation of Risk Assessment Questions Used to Target Blood Lead Screening in Illinois

Received Mar 3, 1998; accepted Jul 22, 1998.

Helen J. Binns*, Susan A. LeBailly*, Ann R. FingarDagger , and Stephen SaundersDagger

From the * Children's Memorial Medical Center, Northwestern University, Chicago, Illinois; and the Dagger  Illinois Department of Public Health, Springfield, Illinois.

Objective.  Beginning in 1995, Illinois law permitted targeted---as opposed to universal---blood lead screening in low-risk areas, which were defined by ZIP code characteristics. State guidelines recommended specific lead risk assessment questions to use when targeting screening. This study was designed to evaluate the sensitivity and specificity of Illinois lead risk assessment questions.

Design.  Parents bringing their 9- or 10- or 12-month and 24-month-old children for health supervision visits at 13 pediatric practices and parents of children (aged 6 through 25 months and who needed a blood lead test) receiving care at 5 local health departments completed a lead risk assessment questionnaire concerning their child. Children had venous or capillary blood lead testing. Venous confirmation results of children with a capillary level >= 10 µg/dL were used in analyses.

Children.  There were 460 children with both blood and questionnaire data recruited at the pediatric practices (58% of eligible) and 285 children (51% of eligible) recruited at local health departments. Of the 745 children studied, 738 provided a ZIP code that allowed their residence to be categorized as in a low-risk (n = 456) or high-risk (n = 282) area.

Results.  Sixteen children (3.5%) living in low-risk areas versus 34 children (12.1%) living in high-risk areas had a venous blood lead level (BLL) >= 10 µg/dL; 1.8% and 5.3%, respectively, had a venous BLL >= 15 µg/dL. For children living in low-risk areas, Illinois mandated risk assessment questions (concerning ever resided in home built before 1960, exposure to renovation, and exposure to adult with a job or hobby involving lead) had a combined sensitivity of .75 for levels >= 10 µg/dL and .88 for levels >= 15 µg/dL; specificity was .39 and .39, respectively. The sensitivity of these questions was similar among children from high-risk areas; specificity decreased to .27 and .28, for BLLs >= 10 µg/dL and >= 15 µg/dL, respectively. The combination of items requiring respondents to list house age (built before 1950 considered high risk) and indicate exposure to renovation had a sensitivity among children from low-risk areas of .62 for BLLs >= 10 µg/dL with specificity of .57; sensitivity and specificity among high-risk area children were .82 and .36, respectively. For this strategy, similar sensitivities and specificities for low and high-risk areas were found for BLLs >= 15 µg/dL.

Conclusions.  The Illinois lead risk assessment questions identified most children with an elevated BLL. Using these questions, the majority of Illinois children in low-risk areas will continue to need a blood lead test. This first example of a statewide screening strategy using ZIP code risk designation and risk assessment questions will need further refinement to limit numbers of children tested. In the interim, this strategy is a logical next step after universal screening.  Key words:  blood lead level, blood lead screening.




This article has been cited by other articles:


Home page
 PediatricsHome page
H. J. Binns, C. Campbell, M. J. Brown, and for the Advisory Committee on Childhood Lead Poiso
Interpreting and Managing Blood Lead Levels of Less Than 10 {micro}g/dL in Children and Reducing Childhood Exposure to Lead: Recommendations of the Centers for Disease Control and Prevention Advisory Committee on Childhood Lead Poisoning Prevention
Pediatrics, November 1, 2007; 120(5): e1285 - e1298.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
G. Rischitelli, P. Nygren, C. Bougatsos, M. Freeman, and M. Helfand
Screening for Elevated Lead Levels in Childhood and Pregnancy: An Updated Summary of Evidence for the US Preventive Services Task Force
Pediatrics, December 1, 2006; 118(6): e1867 - e1895.
[Abstract] [Full Text] [PDF]

Home page
 Pediatr. Rev.Home page
D. Laraque and L. Trasande
Lead Poisoning: Successes and 21st Century Challenges
Pediatr. Rev., December 1, 2005; 26(12): 435 - 443.
[Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Environmental Health
Lead Exposure in Children: Prevention, Detection, and Management
Pediatrics, October 1, 2005; 116(4): 1036 - 1046.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
A. R. Kemper, L. M. Cohn, K. E. Fant, and K. J. Dombkowski
Blood Lead Testing Among Medicaid-Enrolled Children in Michigan
Arch Pediatr Adolesc Med, July 1, 2005; 159(7): 646 - 650.
[Abstract] [Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
L. T. Schwab, J. R. Roberts, and J. R. Reigart
Inaccuracy in Parental Reporting of the Age of Their Home for Lead-Screening Purposes
Arch Pediatr Adolesc Med, June 1, 2003; 157(6): 584 - 586.
[Abstract] [Full Text] [PDF]

Home page
 CMAJHome page
M. D. Sanborn, A. Abelsohn, M. Campbell, and E. Weir
Identifying and managing adverse environmental health effects: 3. Lead exposure
Can. Med. Assoc. J., May 1, 2002; 166(10): 1287 - 1292.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
H. Froehlich, L. M. Ackerson, P. A. Morozumi, and the Pediatric Tuberculosis Study Group of Kaiser P
Targeted Testing of Children for Tuberculosis: Validation of a Risk Assessment Questionnaire
Pediatrics, April 1, 2001; 107(4): e54 - e54.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. Litaker, C. M. Kippes, T. E. Gallagher, and M. E. O'Connor
Targeting Lead Screening: The Ohio Lead Risk Score
Pediatrics, November 1, 2000; 106(5): 69e - 69.
[Abstract] [Full Text]